Literature DB >> 25769664

Epidemiology, antifungal susceptibilities, and risk factors for invasive candidiasis from 2011 to 2013 in a teaching hospital in southwest China.

Shuli Pu1, Siqiang Niu1, Chuanming Zhang1, Xiuyu Xu1, Mei Qin1, Shifeng Huang1, Liping Zhang2.   

Abstract

BACKGROUND: Invasive candidiasis (IC) is the most common cause of invasive fungal infections. Identification of risk factors for such infection may help in the empirical therapeutic decision-making process. We conducted this study to characterize the clinical epidemiology of such infection and to differentiate risk factors between Candida albicans and Candida non-albicans species.
METHODS: We retrospectively evaluated patients with IC from 2011 to 2013. Clinical data, antibiotic therapy, underlying condition, and invasive procedures were analyzed and compared between C. albicans and C. non-albicans species.
RESULTS: C. albicans was the most frequently isolated Candida species (48.6% of all IC patients), although C. non-albicans spp. were more commonly isolated overall. C. albicans, Candida tropicalis, and Candida parapsilosis have a high susceptibility rate to all antifungal agents (>90%), whereas Candida glabrata showed decreased susceptibility to fluconazole and itraconazole. Amphotericin B demonstrated excellent antifungal activity against all Candida species. Univariate analyses showed that IC patients with C. albicans had a higher ratio of older age (p = 0.008), solid tumor (p = 0.029), and hypoproteinemia (p = 0.019), whereas those with C. non-albicans spp. had a higher ratio of hospital length of stay (p = 0.005), usage of corticosteroids (p = 0.011), duration on corticosteroids (p = 0.005), chemotherapy (p = 0.022), hematologic malignancy (p = 0.039), neutropenia (p = 0.030), and usage of glycopeptides (p = 0.002). Multivariate analyses showed that a significant predictor of IC due to C. albicans was hypoproteinemia [odds ratio (95% confidence interval) = 2.133 (1.164-3.908), p = 0.014].
CONCLUSION: C. albicans was the most frequently isolated Candida species. The risk factors between C. albicans and C. non-albicans species are different.
Copyright © 2015. Published by Elsevier B.V.

Entities:  

Keywords:  Antifungal susceptibility; Epidemiology; Invasive candidiasis; Risk factor

Mesh:

Substances:

Year:  2015        PMID: 25769664     DOI: 10.1016/j.jmii.2015.01.005

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  10 in total

Review 1.  Epidemiology of fungal infections in China.

Authors:  Min Chen; Yuan Xu; Nan Hong; Yali Yang; Wenzhi Lei; Lin Du; Jingjun Zhao; Xia Lei; Lin Xiong; Langqi Cai; Hui Xu; Weihua Pan; Wanqing Liao
Journal:  Front Med       Date:  2018-01-11       Impact factor: 4.592

2.  Epidemiology, species distribution, antifungal susceptibility and mortality risk factors of candidemia among critically ill patients: a retrospective study from 2011 to 2017 in a teaching hospital in China.

Authors:  Zengli Xiao; Qi Wang; Fengxue Zhu; Youzhong An
Journal:  Antimicrob Resist Infect Control       Date:  2019-05-29       Impact factor: 4.887

3.  Synergistic Effects and Mechanisms of Combined Treatment With Harmine Hydrochloride and Azoles for Resistant Candida albicans.

Authors:  Xiuyun Li; Xuexin Wu; Yan Gao; Lina Hao
Journal:  Front Microbiol       Date:  2019-10-15       Impact factor: 5.640

4.  Surveillance study of the prevalence, species distribution, antifungal susceptibility, risk factors and mortality of invasive candidiasis in a tertiary teaching hospital in Southwest China.

Authors:  Zhang-Rui Zeng; Gang Tian; Yin-Huan Ding; Kui Yang; Jin-Bo Liu; Jian Deng
Journal:  BMC Infect Dis       Date:  2019-11-07       Impact factor: 3.090

5.  Epidemiology And Antifungal Susceptibility Patterns Of Invasive Fungal Infections From 2012 To 2014 In A Teaching Hospital In Central China.

Authors:  Hui Xu; Shu-Ying Yu; Meng-Lan Zhou; Ya-Ting Ning; Meng Xiao; Xiao-Gai Li; Meng Chen; Fanrong Kong; Sharon Chen; Liang Ming; Ying-Chun Xu
Journal:  Infect Drug Resist       Date:  2019-11-22       Impact factor: 4.003

6.  A High Frequency of Candida auris Blood Stream Infections in Coronavirus Disease 2019 Patients Admitted to Intensive Care Units, Northwestern India: A Case Control Study.

Authors:  Ekadashi Rajni; Ashutosh Singh; Bansidhar Tarai; Kusum Jain; Ravi Shankar; Kalpana Pawar; Vedprakash Mamoria; Anuradha Chowdhary
Journal:  Open Forum Infect Dis       Date:  2021-09-07       Impact factor: 3.835

Review 7.  Distribution and antifungal susceptibility pattern of Candida species from mainland China: A systematic analysis.

Authors:  Hazrat Bilal; Muhammad Shafiq; Bing Hou; Rehmat Islam; Muhammad Nadeem Khan; Rahat Ullah Khan; Yuebin Zeng
Journal:  Virulence       Date:  2022-12       Impact factor: 5.428

Review 8.  Natural Antimicrobial Peptides as Inspiration for Design of a New Generation Antifungal Compounds.

Authors:  Małgorzata Bondaryk; Monika Staniszewska; Paulina Zielińska; Zofia Urbańczyk-Lipkowska
Journal:  J Fungi (Basel)       Date:  2017-08-26

9.  Multilocus Sequence Typing Reveals a New Cluster of Closely Related Candida tropicalis Genotypes in Italian Patients With Neurological Disorders.

Authors:  Fabio Scordino; Letterio Giuffrè; Giuseppina Barberi; Francesca Marino Merlo; Maria Grazia Orlando; Domenico Giosa; Orazio Romeo
Journal:  Front Microbiol       Date:  2018-04-06       Impact factor: 5.640

10.  A 5-Year Review of Invasive Fungal Infection at an Academic Medical Center.

Authors:  Yaling Li; Yali Gao; Xueli Niu; Yutong Wu; Yimei Du; Ying Yang; Ruiqun Qi; Hongduo Chen; Xinghua Gao; Bing Song; Xiuhao Guan
Journal:  Front Cell Infect Microbiol       Date:  2020-10-22       Impact factor: 5.293

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.